Berita Terbaru & Headline Pfizer Inc (PFE)

Black Friday Penawaran

Hingga 60% diskon untuk Profit Pro - Terbatas untuk 500 pengguna pertama

60% diskon untuk Profit Pro - Terbatas untuk 500 pengguna pertama

USD0.170.66%

Perdagangan Orang Dalam

Seeking Alpha

Business Insider

SeekingAlpha

The Wall Street Journal

@Investingcom

Cryptopolitan

Cryptopolitan

SeekingAlpha

SeekingAlpha

@Investingcom

@Investingcom

SeekingAlpha

Apa yang sedang kamu tunggu?Mulai menghasilkan keuntungan hari ini

Membandingkan

Aplikasi seluler keuntungan

Temukan dunia keuangan di genggaman Anda

Pfizer Inc

Pfizer names oncology chief and company veteran Boshoff as chief scientific officer

Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS

Pfizer CEO says he welcomes good ideas as Starboard ups pressure on company

Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales - CNBC

FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease - CNBC

Pfizer wins FDA approval for hemophilia B drug that will be first once-weekly treatment

Pfizer former executives exit activist drive (NYSE:PFE) - Seeking Alpha

Pfizer threatened to sue renegade executives prior to activist schism, Starboard's Smith says - CNBC

Former Pfizer CEO, finance chief step back from Starboard's activist campaign - CNBC

Pfizer wins bid to invalidate GSK's patents over RSV vaccine https://t.co/U4qDo7fLwQ https://t.co/1oT7s25ePe

Activist investor Starboard has informed Pfizer it has taken a stake - Business Insider

Starboard reportedly takes $1 billion stake in Pfizer, seeks changes

Activist Starboard Value has $1 billion Pfizer stake, taps former executives for help, sources say - CNBC

Activist Starboard takes $1B stake in Pfizer - WSJ

Exclusive | Activist Starboard Value Takes $1 Billion Stake in Pfizer - The Wall Street Journal

Pfizer yanks sickle-cell treatment worldwide after possible link to deaths

Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results - CNBC

Pfizer and Valneva report positive results in mid-stage trial of Lyme disease vaccine

Pfizer-BioNTech’s COVID-19-and-flu combination drug meets 1 of 2 trial objectives

Pfizer reports positive results in study of vaccine for immunocompromised adults at risk of severe RSV-related illness

UK regulator authorises updated Pfizer-BioNTech COVID shot targeting JN.1 strain https://t.co/p57xSfPA5r https://t.co/duJDOW0QcD

Pfizer announces positive results from late-stage trial of hemophilia A treatment

Pfizer signals progress on obesity pill, boosting stock

Pfizer moves forward with once-daily version of weight loss pill after setbacks

SEC blasts Pfizer's bid for $75 million from insider trading victims' fund https://t.co/zi2o5UQjRt https://t.co/oqYMmcJzfN

Pfizer defends appellate court’s ‘naming names’ rule in lawsuit over diversity program https://t.co/AJ35cUGXng https://t.co/0EpfCJjqze

UK court gives mixed ruling in Pfizer v Moderna COVID vaccine patents case https://t.co/eCV2WLo1sb https://t.co/ant6wAXYMX

Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline - CNBC

Alnylam’s stock surges as heart drug vies with a Pfizer blockbuster

Pfizer's Duchenne gene therapy fails in late-stage study https://t.co/z9hCGWBuFv https://t.co/re9Wjf19vK

Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds https://t.co/u3wDGUZL8s https://t.co/H7rNkEGC2s

Pfizer aims to save $1.5 billion by 2027 in first wave of new cost cuts

Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial https://t.co/1HCc8JsuZy https://t.co/bHfQ2WNCOK

Moderna wins case in patent dispute with Pfizer, BioNTech over COVID shot https://t.co/pu0pSdZbog https://t.co/gKLeO9j877

⚠️ JUST IN: *PFIZER SAYS YOUNG BOY WHO GOT GENE THERAPY SUFFERED CARDIAC ARREST $PFE https://t.co/VXFOAflzIJ

Pfizer wants the $75 mln left from SAC Capital’s insider trading settlement with SEC https://t.co/gRRWscbh4s https://t.co/01D983fx9G

Pfizer reports patient death in Duchenne gene therapy study https://t.co/4qCybBOOSL https://t.co/GfgTr3Dxvm

AI-Driven Drug Discovery by Pfizer and Austrian Institute Set to Transform Healthcare

S&amp;P index error may have sparked turbulence in Morgan Stanley, Pfizer shares, traders say https://t.co/bV5U63lZZW https://t.co/lXrxneO76p

Ex-Pfizer employee convicted of insider trading on COVID drug trial https://t.co/luI3r8Ww4b https://t.co/phN98DFyMs

Former Pfizer employee goes down for insider trading in COVID drug trial

Pfizer closes Seagen acquisition

Pfizer shares fall as 2024 revenue and profit forecast disappoints

Seagen gains amid options trades, optimism for FTC approval for Pfizer deal

Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops - CNBC

⚠️BREAKING: *PFIZER SHARES TUMBLE 7% AFTER ABANDONING PLANS FOR WEIGHT LOSS PILL $PFE https://t.co/5YVXZADCRj

⚠️BREAKING: *PFIZER SHARES TUMBLE 7% AFTER ABANDONING PLANS FOR WEIGHT LOSS PILL $PFE https://t.co/SrVSxf8PwG

Pfizer pulls the plug on twice-daily obesity pill as study disappoints - Reuters

Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects - CNBC

Pfizer CFO reiterates Seagen closing expected later this year, early next year

S&P index error may have sparked turbulence in Morgan Stanley, Pfizer shares, traders say https://t.co/bV5U63lZZW https://t.co/lXrxneO76p